Stay Up-to-Date With COVID-19 Drug Development
Complete the form below to unlock access to ALL audio articles.
Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.
Below, you'll find a list of our latest COVID-19 drug-related coverage.
Nasal Spray Designed To Treat COVID-19 Set To Begin Clinical Testing
COVID-19: Combining Antiviral and Anti-Inflammatory Drugs Improves Treatment Efficacy
New Administration Route for Remdesivir
Natural Compounds That Inhibit SARS-CoV-2 Discovered Using Virtual Screening
Team Designs Molecule That Inhibits the Replication of Coronaviruses
Antiviral Drug Combo Is Highly Effective Against SARS-CoV-2
Human Nose Organoids Reveal First Steps of SARS-CoV-2 and RSV Infection
Mini Llama Antibodies Could Help To Fight SARS-CoV-2 Variants
A Chewing Gum Designed To Trap SARS-CoV-2
Predicting Where Coronavirus Binds to Human Proteins
Plant-Derived Antiviral for COVID-19 Effective Against All Known SARS-CoV-2 Variants
Portal Helps Researchers Screen COVID-19 Drug Candidates
Inhaled COVID-19 Treatment Advances to Phase 3 Study
Drug Reduces SARS-CoV-2 Infection by Up to 70% in Cell-Based Screen
Masitinib Inhibits the Replication of SARS-CoV-2 in Preclinical Models
Small Trials Suggest Ivermectin May Have Sizeable Effects on COVID-19 Mortality
Considerations When Designing COVID-19 Drug Trials
COVID-19: 160 Drugs Identified That Could Be Repurposed
Treating COVID-19: Protein Engineering Approach Could Accelerate Drug Discovery
Compounds Reduce SARS-CoV-2 Replication in Cultured Cells
Certain Gut Bacteria Produce Compounds That Inhibit SARS-CoV-2
Drug Duo Combats SARS-CoV-2 in Cell Culture Models
Several Existing Drugs Possess Antiviral Activity Against SARS-CoV-2
Computational Tool Helps Find Molecules With COVID-19-Fighting Properties
Organ Chip-Based Testing Supports Rapid Drug Repurposing for COVID-19
Hepatitis C Drugs Boost Remdesivir’s Ability To Inhibit SARS-CoV-2 in Cell Culture
"Nanotraps" Designed To Catch and Clear Coronavirus
Experimental Drug MK-4482 for COVID-19 Is Effective in Hamster Study
Fragment Screen Points to New SARS-CoV-2 Inhibitors
A Long-Acting Injectable Therapy To Treat COVID-19
Asthma Drug Reduces Recovery Time in Non-Hospitalized Patients With COVID-19
Nine Potential New COVID-19 Treatments
Phase 1 Study of Novel Oral Antiviral Against SARS-CoV-2 Initiated
“Silencing” nsp14 Protein To Weaken SARS-CoV-2
Unexpected Binding Between SARS-CoV-2 and Antiviral Drug
Anti-SARS-CoV-2 Drug Candidate Enters Phase 1 Trial in the US
Anti-Androgen Drugs May Disarm COVID-19 Spike Protein
Leprosy Drug Exhibits Potent Antiviral Activities Against SARS-CoV-2
A Potential Target for Anti-COVID-19 Therapies
NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial
Team Discovers Drug Candidates That Can Stop SARS-CoV-2 Replication
Four Potential COVID-19 Drugs Enter Phase 2/3 Testing
Budesonide Reduces Need for Hospitalization in COVID-19 Patients, Phase 2 Study Suggests
Anticancer Drug May Speed Up Recovery of Patients With Severe COVID-19
How Vitamins, Steroids and Antiviral Drugs May Affect SARS-CoV-2
Anticancer Drug Demonstrates Activity Against SARS-CoV-2, Including B.1.1.7 Variant in the Lab
Potential Target for Anti-Viral Drugs To Treat COVID-19
Pilot Study Suggests That Ivermectin Can Help To Treat Mild COVID-19
Two Existing Drugs Could Improve Survival in Patients With Severe COVID-19
Treating COVID-19: Baricitinib Plus Remdesivir Shows Promise in Trial
Drug Rapidly Blocks SARS-CoV-2 Transmission in Animal Model
Team Discovers Inhibitors Capable of Blocking the Uptake of SARS-CoV-2
Creating Drugs To Inhibit SARS-CoV-2 Entry and Replication Simultaneously
Aspirin Being Investigated as a Possible Treatment for COVID-19
Study Suggests That Beta-Blockers Could Be Used To Treat COVID-19
Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease
FDA Approves Remdesivir for COVID-19
Accelerated Screen Identifies 25 Existing Drugs Capable of Disrupting SARS-CoV-2 Cell Entry
Could Amodiaquine Be Effective at Fighting COVID-19?
NIH Study Designed To Identify Promising COVID-19 Treatments for Larger Clinical Trials
ILC Therapeutics Announces COVID-19 Drug Development
Breaking COVID-19’s "Clutch" To Stop Its Spread
Team Identifies Small Molecules That Target SARS-CoV-2 RNA for Destruction
Could a Lipid Be Used To Prevent or Treat SARS-CoV-2 Infection?
REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients
Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection
Team Uncovers New Mechanism of Action Against SARS-CoV-2 by Remdesivir
Drug Shown To Modulate the Inflammatory Response in Severe COVID-19
Tiny Antibody Component Neutralizes SARS-CoV-2 in Animal Models
COVID-19 Phase 3 Trial To Evaluate REGN-COV2 Antibody Cocktail in UK
COVID-19 Drug Discovery and Development – Why Diverse Strategies Are Critical
Synthetic Antiviral Proteins Inhibit SARS-CoV-2 in Lab-Grown Human Cells
The Impact of Genetics on COVID-19 Treatments
Risk of Severe COVID-19 Was Reduced for Patients Taking Blood Pressure Drug
Treating COVID-19 – 21 Existing Drugs Shown To Stop Replication of SARS-CoV-2
Could Steroids Be Used To Combat COVID-19 in Severely Ill Patients?
Ebselen May Be Effective as a Weapon Against Key Coronavirus Enzyme
Machine Learning Approach Identifies Potential Drug Candidates To Treat COVID-19
Study Indicates a Lack of Diversity in COVID-19 Clinical Trials
Existing Alcoholism Drug Potentially Effective Against COVID-19
RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19
Trial Tests Cancer Drug’s Ability To Reduce Respiratory Symptoms of COVID-19
Phase 2 Trial Launched To Investigate LAM-002A as a Treatment for COVID-19
Seaweed Extract Surpasses Remdesivir at Blocking SARS-CoV-2 in Cell Models of COVID-19
Team Identifies 21 Existing Drugs That Stop Replication of SARS-CoV-2
Chloroquine Does Not Inhibit SARS-CoV-2 Infection of Human Lung CellS
Nitric Oxide May Help To Control the Replication and Spread of SARS-CoV-2
Positive Trial Results of SNG001 in Hospitalized COVID-19 Patients
Team Screens Millions of Active Substances Against SARS-CoV-2
Could Heparin Be Used To Stop SARS-CoV-2 From Infecting Human Cells?
Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients
Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators
Why Lopinavir and Hydroxychloroquine Are Ineffective in COVID-19 Patients
Additional Data Announced on Use of Remdesivir for Treatment of COVID-19
Compounds Target Key Enzyme Halting SARS-CoV-2 Replication
Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued
Peptide Combo Could Help Reduce Damage Caused By SARS-CoV-2
Molecules Identified That Shut Down SARS-CoV-2 Polymerase Reaction
Existing Drugs Could Stop SARS-CoV-2 From Hijacking Cells
Clinical Trial Investigates Alpha-1-Antitrypsin for Severe COVID-19 Infection
Lopinavir–Ritonavir: No Clinical Benefit in Hospitalized COVID-19 Patients Studied in RECOVERY Trial
Home-based COVID-19 Trial of Inhaled SNG001 Expanded
Remdesivir Is First COVID-19 Treatment Recommended for EU Authorization
Remdesivir for COVID-19 – Exploring Different Formulations, At-risk Populations and Clinical Progress
UTHealth Evaluates Effectiveness of Canakinumab at Preventing COVID-19-induced Cytokine Release Syndrome
Life-saving Drug for Ventilated COVID-19 Patients Uncovered by UK Experts
Accelerated Efforts To Repurpose Approved Drugs for COVID-19
Combination Drug Treatments for COVID-19 Show Promise in Cell-based Tests
Rheumatoid Arthritis Drug Could Be Repurposed To Treat COVID-19 Patients
Many “First-wave” COVID-19 Clinical Studies Have Significant Design Shortcomings, Says Study
